Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study

Conclusion: RSRT in patients with PMBCL treated with ICHT did not impact unfavorably on LC and patient survival.

Source: In Vivo - April 28, 2020 Category: Research Authors: DE SANCTIS, V., DI ROCCO, A., COX, M. C., VALERIANI, M., CONGEDI, F. P., ANZELLINI, D., MASSARO, M., VULLO, G., FACONDO, G., DE GIACOMO, F., ALFO, M., PROSPERI, D., PIZZICHINI, P., PELLICCIA, S., TAFURI, A., MARTELLI, M., OSTI, M. F. Tags: Clinical Studies Source Type: research